Zai Lab Ltd financial data

Symbol
ZLAB on Nasdaq
Industry
Pharmaceutical Preparations
Location
4560 Jinke Road, Bldg. 1, 4 F, Pudong, Shanghai, China
State of incorporation
Cayman Islands
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 582 % -27.7%
Quick Ratio 25 % +20.1%
Debt-to-equity 23.8 % +40%
Return On Equity -40.2 % -7.03%
Return On Assets -32.5 % -1.12%
Operating Margin -137 % +26.9%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 973 M shares +1%
Entity Public Float 2.7 B USD -15.6%
Common Stock, Value, Issued 6 K USD 0%
Weighted Average Number of Shares Outstanding, Basic 973 M shares +1.22%
Weighted Average Number of Shares Outstanding, Diluted 973 M shares +1.22%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 267 M USD +24%
Revenue from Contract with Customer, Excluding Assessed Tax 291 M USD +26.9%
Cost of Revenue 108 M USD +35.6%
Research and Development Expense 272 M USD -3.2%
Operating Income (Loss) -367 M USD +6.79%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -53.5 M USD -8.81%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -339 M USD +17.3%
Earnings Per Share, Basic -0.35 USD/shares +16.7%
Earnings Per Share, Diluted -0.35 USD/shares +16.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 651 M USD -26%
Accounts Receivable, after Allowance for Credit Loss, Current 60.4 M USD +39.4%
Inventory, Net 37.9 M USD -1.44%
Assets, Current 889 M USD -17.1%
Property, Plant and Equipment, Net 52.4 M USD -10.2%
Operating Lease, Right-of-Use Asset 15.2 M USD -24.6%
Intangible Assets, Net (Excluding Goodwill) 12.4 M USD +738%
Assets 988 M USD -15.5%
Accounts Payable, Current 88.1 M USD +32.8%
Employee-related Liabilities, Current 11.9 M USD +3.91%
Liabilities, Current 192 M USD +54.2%
Operating Lease, Liability, Noncurrent 7.54 M USD -41.9%
Other Liabilities, Noncurrent 325 K USD 0%
Liabilities 226 M USD +34%
Accumulated Other Comprehensive Income (Loss), Net of Tax 39.2 M USD +127%
Retained Earnings (Accumulated Deficit) -2.25 B USD -17.7%
Stockholders' Equity Attributable to Parent 762 M USD -23.9%
Liabilities and Equity 988 M USD -15.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -90.1 M USD -30%
Net Cash Provided by (Used in) Financing Activities 47.5 M USD
Net Cash Provided by (Used in) Investing Activities 3.29 M USD
Common Stock, Shares Authorized 5 B shares 0%
Common Stock, Shares, Issued 978 M shares +1.14%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -39.4 M USD +69.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 45 K USD
Deferred Tax Assets, Valuation Allowance 358 M USD +26%
Operating Lease, Liability 15.2 M USD -25.7%
Depreciation 8.1 M USD -2.41%
Payments to Acquire Property, Plant, and Equipment 974 K USD -72.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -317 M USD +13.6%
Lessee, Operating Lease, Liability, to be Paid 15.6 M USD -26.6%
Property, Plant and Equipment, Gross 84.6 M USD +2.16%
Operating Lease, Liability, Current 7.54 M USD +2.98%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.14 M USD -16.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.44 M USD -1.55%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 460 K USD -48%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.81 M USD -60.5%
Deferred Tax Assets, Operating Loss Carryforwards 295 M USD +22.3%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 822 K USD -52.6%
Operating Lease, Payments 9.32 M USD +15.3%
Amortization of Intangible Assets 700 K USD +40%
Depreciation, Depletion and Amortization 3.01 M USD +13.4%
Deferred Tax Assets, Net of Valuation Allowance 2.83 M USD -24.4%
Share-based Payment Arrangement, Expense 81 M USD +23.5%
Interest Expense 113 K USD